Preclinical characterization of a selective alpha-7 neuronal nicotinic acetylcholine receptor agonist ABT-126: A novel therapeutic agent for the treatment of cognitive impairment in Alzheimer's disease and schizophrenia

✍ Scribed by Bitner, Robert; Anderson, David; Drescher, Karla; Kohlhaas, Kathy; Gronlien, Halvard; Hu, Min; Li, Jinhe; Markosyan, Stella; Marsh, Kennan; Mohler, Eric; Nikkel, Arthur; Radek, Richard; Robb, Holly; Schrimpf, Michael; Waring, Jeffrey; Lee, Chih-Hung; Gopalakrishnan, Murali

• Book ID: 122701488
• Publisher: Elsevier Science
• Year: 2013
• Tongue: English
• Weight: 75 KB
• Volume: 9
• Category: Article
• ISSN: 1552-5260
• DOI: 10.1016/j.jalz.2013.05.1755